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Rationale
Oral food inmunotherapy is a promising therapeutic
aproach in patients with persistent cow’s milk allergy
(CMA). Although it seems that these protocols show a
better outcome in patients with “milder” symptoms (i.e.
non anaphylactic reactions) there are controversial
results in highly sensitized subjects.
Methods
We select patients with persistent CMA and severe
uncontrolled anaphylactic symptoms despite a correct
restrictive diet. We performed a two-day desensitization
procedure at the Pediatric Critical Care Unit in our
Institution. The second phase was weekly scheduled in
the Outpatient clinic to reach a final cumulative dose of
250 ml of undiluted milk. Clinical and serological date
were collected every six month for a five-year period.
Results
Fifteen children (2-16 y.o.) were included. All children
reached the final dose of 250 ml of undiluted milk in
less than ten weeks. Clinical follow-up every 6 months
remained during 5 years to register all adverse reactions
and possible factors involved. Serological changes were
obtained every six months during the subsequent five
years, including specific IgE and IgG4.
Conclusion
Anaphylactic CMA patients may benefit from rush oral
Cow’s Milk immunotherapy. Clinical and serological
changes have been found both at early and long-term
follow-up. Several factors were involved in reactions for
temporary loss of tolerance.
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